NH TherAguix announces the arrival of Dr. Olivier de Beaumont as Chief Medical Officer
Meylan, France, September 9th, 2022 NH TherAguix (“NHT”), a French clinical biotech specialized in the development of innovative nanomedicines for the treatment of cancer by radiotherapy, announces today the arrival of Dr. Olivier de Beaumont as Chief Medical Officer from September 22. Oncology specialist, Olivier de Beaumont will bring his expertise to NHT clinical development. […]